English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. CONTACT INFO Doug Scott Centers for Disease Control and Prevention (CDC) Roybal Campus 1600 Clifton Road MS-A16 Atlanta, GA 30329-4027 Phone: 404-639-2836 Email: DScott1@cdc.gov Including the Economic Value of Mortality Risk Reductions in Cost-Benefits Analysis (CBA) of Healthcare-Associated Infections R. Douglas Scott II, PhD1; Rachel B. Slayton, PhD1; James Baggs, PhD1; Steven D. Culler, PhD1,2; John A. Jernigan, MD, MS1 1Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA USA, 2Rollins School of Public Health, Emory University, Atlanta, GA USA